ROSEMARY MAZANET - 16 Jun 2022 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
ONCT
Transactions as of
16 Jun 2022
Transactions value $
$0
Form type
4
Filing time
17 Jun 2022, 18:00:48 UTC
Previous filing
03 May 2022
Next filing
21 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONCT Stock Options Award $0 +25K $0.00 25K 16 Jun 2022 Common Stock 25K $1.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.